Johnson & Johnson proposes $5.5 billion resolution of ovarian cancer talc claims
Whether participation reaches the 95% threshold will determine whether most claims in the largest pending MDL settle or continue in litigation.
Insights
Analysis by the firm's attorneys and briefs on public developments, with links to the primary sources. Unless stated otherwise, the firm is not counsel in the matters described.
Fourth Circuit reverses class certification in Boeing 737 MAX investor suit
In federal courts in Maryland, Virginia, West Virginia, North Carolina, and South Carolina, investors seeking class certification now face a more demanding damages showing.
Seventh Circuit: texts fall outside the TCPA's Do-Not-Call private right
In federal courts in Illinois, Indiana, and Wisconsin, Do-Not-Call claims based on texts are now foreclosed, while courts elsewhere may decide differently.
Supreme Court leaves Texas app store age-verification law in effect
Texas's age-verification and parental-consent requirements for app downloads can be enforced while the challenge continues.
Court upholds Twitter investor verdict against Musk, trims one statement
Securities class actions rarely reach a jury, and the ruling shows how a court tests loss causation and class certification after a verdict for investors.
Travel app Hopper to pay $35 million to settle FTC fee allegations
The case targets pre-checked add-on fees and incomplete price disclosure, conduct that also appears in private consumer class actions.
Supreme Court: federal pesticide law preempts Roundup cancer-warning claim
Failure-to-warn claims are central to many pending Roundup cases; how the ruling applies to claims that do not depend on the label will be decided case by case.
Chancery applies SB 21 director-independence presumption for the first time
Shareholders bringing derivative claims in Delaware face a higher pleading bar when they allege that exchange-independent directors are conflicted.
Settlement announced for most Depo-Provera meningioma claims
Under Case Management Order No. 14, settlement registration runs through November 30, 2026, and the court set an initial bellwether trial for December 7, 2026, subject to its rulings on preemption and expert evidence.
Supreme Court: no private suits under Investment Company Act Section 47(b)
Closed-end fund shareholders lose a federal path for undoing fund governance measures such as control-share provisions.
New MDL for Boston Scientific spinal cord stimulator claims
Federal Boston Scientific stimulator injury cases now proceed before one judge; the Panel reported 29 actions pending as of September 1, 2026.
Federal Dupixent lymphoma lawsuits centralized in New Jersey
Pretrial proceedings for federal Dupixent cases now run before one judge; the Panel reported 35 actions pending as of September 1, 2026.
Supreme Court: SEC disgorgement does not require proof of investor loss
Disgorgement is one of the ways money is returned to harmed investors, and the ruling removes a defense argument against it.
If something happened to more people than you, tell us.
Many class actions begin with one person who noticed a pattern. Reviewing your information costs nothing and creates no obligation.